You are viewing: UK European Infection Control Market analysis

The UK European Infection Control Market was valued at $2402.5 Million in 2025 and projected to reach to $3327.9 Million by 2030, representing a compound annual growth rate of 6.7%. The UK infection control market is poised for steady growth through 2030, driven by ongoing NHS modernization initiatives and increased focus on reducing healthcare-associated infections.

UK European Infection Control Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK European Infection Control Market Trends and Insights

  • The UK market is driven by heightened awareness of healthcare-associated infections, stringent regulatory frameworks, and substantial investment in NHS infection prevention protocols.
  • The UK's robust healthcare infrastructure and commitment to patient safety standards position it as a key market within Europe's infection control sector..

Key Market Statistics

  • CAGR (2025-2030) 6.7% CAGR
  • Market Size, 2025 ~USD 2402.5 Million
  • Forecast, 2030 ~USD 3327.9 Million
  • Country UK

UK European Infection Control Market Overview

Market Valuation :

The UK infection control market is valued at $2,402.5 million in 2025, with projections reaching $3,327.9 million by 2030, representing significant growth in healthcare safety investments.

NHS-Driven Growth :

Substantial investment in NHS infection prevention protocols and heightened awareness of healthcare-associated infections (HAIs) are primary drivers of market expansion across UK healthcare facilities.

Regulatory Compliance :

Stringent UK regulatory frameworks and compliance requirements mandate robust infection control measures, creating sustained demand for advanced prevention solutions and monitoring systems.

Healthcare Infrastructure :

The UK's robust healthcare infrastructure and commitment to patient safety standards position it as a mature market with consistent adoption of innovative infection control technologies.

UK European Infection Control Market Dynamics

  • Post-pandemic awareness has elevated infection prevention as a strategic priority across UK hospitals, clinics, and care facilities.
  • Regulatory pressures and patient safety mandates continue to fuel investment in advanced disinfection technologies, personal protective equipment, and surveillance systems.
  • The market will benefit from technological innovations in sterilization and antimicrobial solutions tailored to UK healthcare standards.
  • Collaboration between NHS trusts and private healthcare providers will expand market opportunities, while budget constraints may drive demand for cost-effective, efficient infection control solutions..

Related Ecosystem

Key Takeaways

  • The UK infection control market will grow from $2,402.5M (2025) to $3,327.9M (2030) at a 6.7% CAGR.
  • The UK's stringent regulatory environment and NHS focus on infection prevention drive sustained market expansion.
  • The UK market benefits from advanced healthcare infrastructure and high adoption of infection control technologies.
  • The UK represents a significant portion of the European infection control market with consistent year-on-year growth.

European Infection Control Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment ENDOSCOPE REPROCESSING PRODUCTS (Product & Service)
Forecast Period 2025-2030
Growth Rate CAGR of 6.6% from 2025 to 2030
Largest Segment HOSPITALS & CLINICS (End User)
Market Size Base Year (Billions) ~USD 14.95 (2025)
Revenue Forecast (Billions) ~USD 20.58 (2030)
Segments Covered Product & Service, Type, Product Type, Formulation, Epa Classification, End User, Formulation Type, Epa Classification Type, End Users

UK European Infection Control Market Report Segmentation

9 segment dimensions are covered across the global market.

By Product & Service

  • Cleaning & Disinfection Products
  • Endoscope Reprocessing Products
  • Other Infection Control Products
  • Protective Barriers
  • Sterilization Products & Services

By Type

  • Automated Endoscope Reprocessing Equipment
  • Biological Indicators
  • Chemical Indicators
  • Cleaners & Disinfectant Equipment
  • Consumables & Accessories
  • Contract Sterilization Services
  • Covers & Closures
  • Disinfectants
  • Disinfection & Cleaning Accessories
  • Dry Heat Sterilizers
  • E-Beam Sterilization Services
  • Endoscope Reprocessing Consumables
  • Endoscope Reprocessing Equipment & Solutions
  • Endoscope Tracking Solutions
  • Eto Sterilization Services
  • Eto Sterilizers
  • Face Masks
  • Flusher Disinfectors
  • Formaldehyde Sterilizers
  • Gamma Sterilization Services
  • Gloves
  • Goggles
  • Heat Sterilization Equipment
  • Hydrogen Peroxide Sterilizers
  • Low-Temperature Sterilization Equipment
  • Lubricants & Cleaning Solutions
  • Medical Nonwovens
  • Moist Heat Sterilizers
  • Other Cleaning & Disinfection Equipment
  • Other Contract Sterilization Services
  • Other Endoscope Reprocessing Equipment
  • Other Low-Temperature Sterilizers
  • Radiation Sterilization Equipment
  • Steam Sterilization Services
  • Sterilization Accessories
  • Sterilization Equipment
  • Sterilization Indicators
  • Sterilization Lubricants
  • Sterilization Pouches
  • Surgical Drapes
  • Surgical Gowns
  • Ultrasonic Cleaners
  • Uv Disinfectors
  • Washer Disinfectors

By Product Type

  • Hand Disinfectants
  • Instrument Disinfectants
  • Skin Disinfectants
  • Surface Disinfectants

By Formulation

  • Disinfectant Sprays
  • Disinfectant Wipes
  • Liquid Disinfectants

By Epa Classification

  • High-Level Disinfectants
  • Intermediate-Level Disinfectants
  • Low-Level Disinfectants

By End User

  • Food Industry
  • Hospitals & Clinics
  • Life Sciences Industry
  • Medical Device Companies
  • Other End Users
  • Pharmaceutical Companies

By Formulation Type

  • Disinfectant Sprays
  • Disinfectant Wipes
  • Liquid Disinfectants

By Epa Classification Type

  • High-Level Disinfectants
  • Intermediate-Level Disinfectants
  • Low-Level Disinfectants

By End Users

  • Food Industry
  • Hospitals & Clinics
  • Life Sciences Industry
  • Medical Device Companies
  • Other End Users
  • Pharmaceutical Companies

Target Audience

  • NHS Trust Procurement Teams : Need market intelligence on infection control solutions, supplier benchmarking, and cost-effectiveness data to optimize procurement decisions and infection prevention budgets.
  • Medical Device Manufacturers : Require UK market sizing, regulatory pathways, distribution channels, and competitive positioning to develop go-to-market strategies and expand product portfolios in Britain.
  • Healthcare Facility Managers : Seek insights on best-practice infection control protocols, technology adoption trends, and vendor performance metrics to enhance patient safety and operational efficiency.
  • Private Equity & Investors : Need comprehensive market analysis, growth forecasts, and investment opportunities to evaluate acquisition targets and funding decisions in the UK infection control sector.
  • Healthcare Consultants & Advisors : Require detailed market data, trend analysis, and competitive intelligence to advise clients on infection prevention strategies, technology selection, and market opportunities.

Reasons to Buy this Report

  • NHS Market Intelligence : Gain detailed insights into NHS procurement trends, infection prevention budgets, and strategic priorities to identify partnership and sales opportunities across UK healthcare trusts.
  • Regulatory Compliance Guidance : Understand UK-specific regulatory requirements, compliance standards, and quality certifications needed to successfully market infection control products and services in the British healthcare system.
  • Competitive Landscape Analysis : Identify key competitors, market share distribution, and differentiation strategies among UK-based and international infection control providers operating in the British market.
  • Growth Opportunity Mapping : Discover high-growth segments, emerging technologies, and underserved healthcare facilities within the UK to prioritize market entry and expansion strategies effectively.
  • Investment Decision Support : Access comprehensive market data, financial projections, and trend analysis to support investment decisions, business planning, and resource allocation for UK healthcare ventures.

Frequently asked questions

What is the current size of the UK infection control market?

The UK infection control market is estimated at $2,402.5 million in 2025.

What is the projected size of the UK infection control market by 2030?

The UK infection control market is forecast to reach $3,327.9 million by 2030.

What is the growth rate of the UK infection control market?

The UK infection control market is expected to grow at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2030.

What factors are driving growth in the UK infection control market?

Key drivers include heightened awareness of healthcare-associated infections, stringent regulatory frameworks, NHS investment in infection prevention, and advanced healthcare infrastructure.

How does the UK market compare to the broader European market?

The UK market grows at 6.7% CAGR, slightly outpacing the global European market CAGR of 6.6%, reflecting strong domestic demand and regulatory compliance.

RESEARCH METHODOLOGY

The study involved primary activities in estimating the current market size for the European infection control market. Exhaustive secondary research was done to collect information on the European infection control industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the European infection control market.

The four steps involved in estimating the market size are:

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases, white papers, annual reports, investor presentations, SEC filings of companies, and publications from government sources [such as the US FDA, World Health Organization (WHO), CDC, ISO, Agency for Healthcare Research and Quality] were referred to identify and collect information for the European infection control market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the European infection control market. The primary sources from the demand side include Hospitals & Clinics, Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

The following is a breakdown of the primary respondents:

European Infection Control Market

Note 1: Other designations include sales, marketing, and product & service managers.

Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the market value, annual revenues were calculated based on the revenue mapping of leading product & service manufacturers and OEMs active in the European infection control market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. The European infection control market was split into various segments and sub-segments based on:

  • List of major players operating in the products & services market at the regional and/or country level
  • Products & service mapping of European infection control providers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from European infection control (or the nearest reported business unit/products & services category)
  • Extrapolation of the revenue mapping of the listed major players to derive the market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the European infection control market

The above data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

The research methodology used to estimate the market size includes the following:

European Infection Control Market

Data Triangulation

The total market was split into several segments after arriving at the overall market size by applying the abovementioned process. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Infection control refers to eliminating all forms of microorganisms from objects and surfaces to ensure sterility of the object/surface, making it suitable for human use/reuse and avoiding contamination and the spread of diseases. The infection control market for products & services used for cleaning, disinfecting, and sterilizing objects/surfaces in hospitals & clinics, medical device companies, pharmaceutical companies, and the food & life science industries.

Stakeholders

  • European infection control product & service manufacturers
  • European infection control vendors & distributors
  • Hospitals
  • Clinical & diagnostic laboratories
  • Pharmaceutical & biopharmaceutical companies
  • Venture capitalists & investors

Report Objectives

  • To define, describe, analyze, and forecast the European infection control (LFA) market by product & service, end user, and countries
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets concerning individual growth trends, prospects, and contributions to the overall European infection control market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments concerning European countries
  • To profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
  • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product & service excellence
  • To study the impact of AI/Generative AI on the market, along with the macroeconomic outlook for each region

Get the Full European Infection Control Market Report

Full forecast, segment splits, and company analysis for all European Infection Control Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status